Compare Danaos Corporation (DAC) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaos Corporation vs Neurocrine Biosciences Inc — how do they compare? Danaos Corporation trades at $129.89 (market cap $2.36B), while Neurocrine Biosciences Inc trades at $170.05 (market cap $17.30B). The key difference: Neurocrine Biosciences Inc is far larger — about 7.3× Danaos Corporation's market cap, and Danaos Corporation pays a 2.78% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| DAC | NBIX | |
|---|---|---|
Market Cap | $2.36B | $17.30B |
Sector | Technology | Health |
52-Week High | $134.63 | $180.55 |
52-Week Low | $84.05 | $123.10 |
Enterprise Value | $2.36B | $16.39B |
Dividend Yield | 2.78% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
